LONG-LASTING TOPHACEOUS GOUT, ATYPICAL PROGRESS OF A DISEASE
Abstract and keywords
Abstract (English):
The peculiarity of the presented case of tophaceous gout is the absence in the whole course of a disease of typical acute attacks and complete function retention of joints while a lot of growing and spontaneously blowing up tophi are formed. The achievements of a target level of uric acid in blood serum (less than 0,360 mmol/L) and maintenance of it for a long period helps to achieve the reduction of patients tophi and in some cases their complete resorption

Keywords:
allopurinol, diet, gout, tophi, febuxostat
References

1. Diagnostiki i lechenie v revmatologii. Problemnyy podkhod/ Kevin Payl, Li Kennedi; per. s angl. Pod red. N.A. Shostak. — M.: GEOTAR-Media, 2011. — 368 s.

2. Revmaticheskie zabolevaniya v 3 t. T.II. Zabolevaniya kostey i sustavov: rukovodstvo/pod red. Dzhona Kh. Klippela, Dzhona Kh. Stouna, Lesli Dzh. Krofford, Peyshens Kh. Uayt; per. s angl. pod red. E.L. Nasonova, V.A. Nasonovoy, Yu.A. Olyunina. — M.: GEOTAR- Media, 2014. — 520 s.: il.

3. V.G. Barskova, E.V. Il´inykh, E.L. Nasonov./Febuksostat — novyy preparat v terapii podagry. Nauchno-prakticheskaya revmatologiya, 2011, № 2, s. 52–58.

4. Grabowski B.A., Vernillet L., Khosravan R. et al. Absorbtion, metabolism and excretion of febuxostat, a novel nonpurin selective inhibitor of xantin oxidase, in helthy male subject. Drag Metab Rev 2005; 37:111.

5. Khosravan R., Kukulka M.J., Wu J.T. et al.The effect of age and gender on pharmacokinetics, pharmacodinamics, and safety of febuxostat, a novel nonpurin selective inhibitor of xantin oxidase, J Clin Pharmacol 2008, 48: 1014–24.

Login or Create
* Forgot password?